Novo Nordisk’s diabetes treatments Tresiba and Ryzodeg have been approved for use in the European Union. The European Commission has granted marketing authorisation for Novo Nordisk’s adult ...

Notably, GZR4 injection achieved superior HbA1c reduction in patients with inadequate glycemic control on prior basal insulin therapy compared to once-daily insulin degludec (Tresiba ®).

Notably, GZR4 injection achieved superior HbA1c reduction in patients with inadequate glycemic control on prior basal insulin therapy compared to once-daily insulin degludec (Tresiba ®).

The report includes historical data from 2023 to 2024 and forecasts until 2033. The insulin pen market in the United States has experienced remarkable growth over the last few years.

The United States insulin pen market size was valued at USD 4.2 billion in 2024 and is projected to hit around USD 8.1 billion by 2033, growing at a CAGR of 6.9% during the forecast period 2025 to ...

Dublin, June 25, 2025 (GLOBE NEWSWIRE) -- The "United States Insulin Pens Market Size, Insights, Competitive Landscape, and Forecast, 2025 - 2033" report has been added to ResearchAndMarkets.com's ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first ...

Technology can fail and that means for insulin pump users, backup insulin and knowing how to navigate customer care and technical support is critical.

The insulin discovery we forgot.Editorial Policies Community standards Republishing guidelines Friends of The Conversation Analytics Our feeds Donate Get newsletter Who we are Our charter Our team ...

Study design. This prospective, randomized, controlled, parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized ...

Purpose: Patient satisfaction, safety and efficacy outcomes, and cost savings with insulin pens versus conventional insulin delivery via vials and syringes in hospitalized patients with diabetes ...

CDSCO allows Lilly to launch weight-loss drug Mounjaro in pen format The KwikPen is a multi-dose, single-patient-use prefilled pen designed for once-in-a week administration ...